Ep. 235: “New Therapies for Degenerative Disease” Featuring Dr. Lorenz Studer
Podcast: Play in new window | Download | Embed Subscribe: RSS
Podcast: Play in new window | Download | Embed
Dr. Lorenz Studer is the Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Institute. His lab exploits recent advances in stem cell biology to develop new therapies for degenerative diseases and cancer. Their projects involve directing the fate and age of hPSCs, modeling diseases, and developing cell therapies. He talks about his journey into the stem cell field and co-founding BlueRock Therapeutics. He also discusses the challenges of developing cell therapies at scale, strategies to target cognition loss in Parkinson’s disease, and combining basic and translational research.
Featured Products and Resources:
- Register for ISSCR 2023, taking place in Boston June 14-17.
- Explore ways to assess your human pluripotent stem cells and essential quality attributes.
The Stem Cell Science Round Up
iPSC Organization – Researchers mapped the 3D cellular organization of more than 200,000 live cells.
Modeling the Gut–Immune Interface – Scientists transplanted human intestinal organoids into humanized mice to study human intestinal–immune crosstalk during development.
Deep Learning to Predict Arrhythmia Risk – Deep learning can identify in vitro arrhythmic features that correlate with clinical arrhythmia.
Gastric Isthmus Stem Cells – Researchers developed a monolayer 2D culture system to study the isthmus and uncovered a role for Sox2 in enterochromaffin cells.
Photo Reference: Courtesy of Dr. Lorenz Studer